174 related articles for article (PubMed ID: 9490645)
1. Analysis of CD44 interactions with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulfate.
Esford LE; Maiti A; Bader SA; Tufaro F; Johnson P
J Cell Sci; 1998 Apr; 111 ( Pt 7)():1021-9. PubMed ID: 9490645
[TBL] [Abstract][Full Text] [Related]
2. Differential use of chondroitin sulfate to regulate hyaluronan binding by receptor CD44 in Inflammatory and Interleukin 4-activated Macrophages.
Ruffell B; Poon GF; Lee SS; Brown KL; Tjew SL; Cooper J; Johnson P
J Biol Chem; 2011 Jun; 286(22):19179-90. PubMed ID: 21471214
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin sulfate addition to CD44H negatively regulates hyaluronan binding.
Ruffell B; Johnson P
Biochem Biophys Res Commun; 2005 Aug; 334(2):306-12. PubMed ID: 16002044
[TBL] [Abstract][Full Text] [Related]
4. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.
Kawashima H; Hirose M; Hirose J; Nagakubo D; Plaas AH; Miyasaka M
J Biol Chem; 2000 Nov; 275(45):35448-56. PubMed ID: 10950950
[TBL] [Abstract][Full Text] [Related]
5. TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44.
Levesque MC; Haynes BF
Cell Immunol; 1999 May; 193(2):209-18. PubMed ID: 10222064
[TBL] [Abstract][Full Text] [Related]
6. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.
Lesley J; English N; Perschl A; Gregoroff J; Hyman R
J Exp Med; 1995 Aug; 182(2):431-7. PubMed ID: 7543138
[TBL] [Abstract][Full Text] [Related]
7. CD44 binds a chondroitin sulfate proteoglycan, aggrecan.
Fujimoto T; Kawashima H; Tanaka T; Hirose M; Toyama-Sorimachi N; Matsuzawa Y; Miyasaka M
Int Immunol; 2001 Mar; 13(3):359-66. PubMed ID: 11222505
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan induces cell death in activated T cells through CD44.
Ruffell B; Johnson P
J Immunol; 2008 Nov; 181(10):7044-54. PubMed ID: 18981124
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M and transforming growth factor-beta 1 induce post-translational modification and hyaluronan binding to CD44 in lung-derived epithelial tumor cells.
Cichy J; Pure E
J Biol Chem; 2000 Jun; 275(24):18061-9. PubMed ID: 10751416
[TBL] [Abstract][Full Text] [Related]
10. CD44 and hyaluronan binding by human myeloid cells.
Smadja-Joffe F; Legras S; Girard N; Li Y; Delpech B; Bloget F; Morimoto K; Le Bousse-Kerdiles C; Clay D; Jasmin C; Levesque JP
Leuk Lymphoma; 1996 May; 21(5-6):407-20, color plates following 528. PubMed ID: 9172805
[TBL] [Abstract][Full Text] [Related]
11. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
12. CD44-mediated hyaluronan binding marks proliferating hematopoietic progenitor cells and promotes bone marrow engraftment.
Lee-Sayer SSM; Dougan MN; Cooper J; Sanderson L; Dosanjh M; Maxwell CA; Johnson P
PLoS One; 2018; 13(4):e0196011. PubMed ID: 29684048
[TBL] [Abstract][Full Text] [Related]
13. Generation of artificial proteoglycans containing glycosaminoglycan-modified CD44. Demonstration of the interaction between rantes and chondroitin sulfate.
Wolff EA; Greenfield B; Taub DD; Murphy WJ; Bennett KL; Aruffo A
J Biol Chem; 1999 Jan; 274(4):2518-24. PubMed ID: 9891023
[TBL] [Abstract][Full Text] [Related]
14. Keratan sulfate modification of CD44 modulates adhesion to hyaluronate.
Takahashi K; Stamenkovic I; Cutler M; Dasgupta A; Tanabe KK
J Biol Chem; 1996 Apr; 271(16):9490-6. PubMed ID: 8621620
[TBL] [Abstract][Full Text] [Related]
15. Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells.
Toyama-Sorimachi N; Kitamura F; Habuchi H; Tobita Y; Kimata K; Miyasaka M
J Biol Chem; 1997 Oct; 272(42):26714-9. PubMed ID: 9334256
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan binding by cell surface CD44.
Lesley J; Hascall VC; Tammi M; Hyman R
J Biol Chem; 2000 Sep; 275(35):26967-75. PubMed ID: 10871609
[TBL] [Abstract][Full Text] [Related]
17. MDA-MB-231 breast cancer cell viability, motility and matrix adhesion are regulated by a complex interplay of heparan sulfate, chondroitin-/dermatan sulfate and hyaluronan biosynthesis.
Viola M; Brüggemann K; Karousou E; Caon I; Caravà E; Vigetti D; Greve B; Stock C; De Luca G; Passi A; Götte M
Glycoconj J; 2017 Jun; 34(3):411-420. PubMed ID: 27744520
[TBL] [Abstract][Full Text] [Related]
18. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
19. Functional hierarchy of simultaneously expressed adhesion receptors: integrin alpha2beta1 but not CD44 mediates MV3 melanoma cell migration and matrix reorganization within three-dimensional hyaluronan-containing collagen matrices.
Maaser K; Wolf K; Klein CE; Niggemann B; Zänker KS; Bröcker EB; Friedl P
Mol Biol Cell; 1999 Oct; 10(10):3067-79. PubMed ID: 10512851
[TBL] [Abstract][Full Text] [Related]
20. A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response?
Johnson P; Maiti A; Brown KL; Li R
Biochem Pharmacol; 2000 Mar; 59(5):455-65. PubMed ID: 10660111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
